Using blood tests to detect cancer earlier
Official title: Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit
Funded at Fred Hutchinson Cancer Center · NIH-10933531 · Data updated 2026-11-12
This study is looking at a new way to find cancer earlier by testing blood or other body fluids, which could help patients get diagnosed more accurately and with less invasive methods, leading to earlier treatment options.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | September 22, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $752,400 |
| NIH project number | 5U24CA288185-02 |
| Project ID | NIH-10933531 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals at high risk for cancer or those with early-stage cancer who are undergoing diagnostic evaluation.
✕Less likely to help
Patients with advanced-stage cancer or those who do not have cancer may not benefit from this research.
What this research studies
This research focuses on liquid biopsy, a method that analyzes biomarkers in blood or other body fluids to detect cancer at an earlier stage than traditional methods. By examining circulating tumor cells, DNA, and other cancer-related substances, the study aims to improve the accuracy and effectiveness of cancer diagnosis. The project will also address challenges in validating new testing techniques across different populations and cancer types, ensuring that the findings are applicable and reliable. Patients may benefit from less invasive testing and potentially earlier treatment options.
Why it matters
Potential benefit: If successful, this research could lead to earlier cancer detection, improving treatment outcomes and reducing mortality rates.
How similar studies have gone: Previous research has shown promise in using liquid biopsy for cancer detection, indicating that this approach has potential for significant advancements in early diagnosis.
Where this research is happening
-
Fred Hutchinson Cancer Center
Seattle, United States Active
Researchers
- Principal investigator: Zheng, Yingye — Fred Hutchinson Cancer Center
- Study coordinator: Zheng, Yingye
Related research
Other NIH-funded projects on the same topics.
-
Towards a blood-based test using nanophotonic exosomes to screen and diagnose liver cancer
A new blood test using tiny particles shed by liver cancer cells aims to screen for hepatocellular carcinoma earlier and more accurately.
-
Liquid biopsy test to screen for lymphoma in people with HIV
A new blood test called High Density Methyl-Seq is being checked to see if it can detect lymphoma early in people living with HIV.
-
Liquid biopsy and oxygen therapy to guide glioblastoma treatment
A patient-focused study exploring a blood-based test and a safe oxygen therapy to help doctors tell true tumor growth from treatment effects in adults with glioblastoma treated with chemoradiation.
-
Liquid biopsy to monitor LMS treatment and resistance
A patient-centered look at using blood tests to see how well LMS treatment is working and when resistance to therapy appears.
-
Imagnostix: a simple blood-based test to flag Alzheimer’s risk
A new blood-based test called Imagnostix aims to help identify people who may be developing Alzheimer’s disease earlier and more cheaply than current methods.
-
Multi-omic liquid biopsy to guide immunotherapy in colorectal and anal cancers
A patient-facing overview of a study testing blood-based biomarkers (ctDNA and extracellular RNA) to better tailor immunotherapy for colorectal and anal cancer patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.